triple g retatrutide G,” also known as retatrutide, represents the next generation of subcutaneous therapies for metabolic disease. Exciting advancements! Thanks for posting Dr Brian! Triple G 6 mg |

Phase 2 clinical trial data published in the New England Journal of Medicine in 2023 demonstrated substantial mean reductions in body weight in some participants exceeding 20% over 48 weeks alongside improvements in glycaemic control and cardiometabolic markers

For example, someone may have a prescription for 15 milligrams of Mounjaro but only take a portion of it

Less bulk in your stool

Several fiber supplements are available at most grocery and drug stores

Dose-dependent increases in heart rate were also observed, consistent with the glucagon receptor agonism component of the drug, and this warrants careful monitoring in individuals with pre-existing cardiac conditions

GLP-1 receptor agonists like semaglutide work by slowing gastric emptying and signaling fullness to your brainbut the time you inject can influence how well these effects align with your eating patterns